A carregar...
AB 11. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with lung cancer and bone metastases
BACKGROUND: Breakthrough cancer pain (BTcP) represents an important clinical challenge in the care of patients with cancer. Oral opioids have traditionally been the only available drugs for BTcP. However, the onset and duration of action of oral opioids may not be suitable for treating many episodes...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pioneer Bioscience Publishing Company
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537363/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|